Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Hatipoğlu U[au]:

α1-Antitrypsin Deficiency. Hatipoğlu U et al. Clin Chest Med. (2016)

What is the role of roflumilast in chronic obstructive pulmonary disease? Lau C et al. Cleve Clin J Med. (2017)

A rational framework for selecting modes of ventilation. Mireles-Cabodevila E et al. Respir Care. (2013)

Search results

Items: 39

1.

Electronic inhaler monitoring and healthcare utilization in chronic obstructive pulmonary disease.

Alshabani K, Attaway AA, Smith MJ, Majumdar U, Rice R, Han X, Wang X, Hatipoğlu U.

J Telemed Telecare. 2019 May 16:1357633X19850404. doi: 10.1177/1357633X19850404. [Epub ahead of print]

PMID:
31096842
2.

Lung Volume Reduction Surgery in the United States From 2007 to 2013: Increasing Volumes and Reason for Caution.

Attaway AH, Hatipoğlu U, Murthy S, Zein J.

Chest. 2019 May;155(5):1080-1081. doi: 10.1016/j.chest.2019.01.032. No abstract available.

PMID:
31060695
3.

Exacerbations and health care resource use among patients with COPD in relation to blood eosinophil counts.

Müllerová H, Hahn B, Simard EP, Mu G, Hatipoğlu U.

Int J Chron Obstruct Pulmon Dis. 2019 Mar 22;14:683-692. doi: 10.2147/COPD.S194367. eCollection 2019.

4.

Predictors of Response to Endobronchial Coil Therapy in Patients With Advanced Emphysema.

Slebos DJ, Cicenia J, Sciurba FC, Criner GJ, Hartman JE, Garner J, Deslée G, Delage A, Jantz M, Marquette CH, Strange C, Hatipoglu U, Mehta AC, LaPrad AS, Schmid-Bindert G, Herth FJF, Shah PL; RENEW Study Group.

Chest. 2019 May;155(5):928-937. doi: 10.1016/j.chest.2019.02.012. Epub 2019 Feb 21.

PMID:
30797746
5.

Chronic obstructive pulmonary disease: More than meets the eye.

Hatipoğlu U.

Ann Thorac Med. 2018 Jan-Mar;13(1):1-6. doi: 10.4103/atm.ATM_193_17.

6.

Supplemental oxygen in patients with stable chronic obstructive pulmonary disease: evidence from Nocturnal Oxygen Treatment Trial to Long-term Oxygen Treatment Trial.

Hatipoğlu U, Stoller JK.

Curr Opin Pulm Med. 2018 Mar;24(2):179-186. doi: 10.1097/MCP.0000000000000461. Review.

PMID:
29319542
7.

Predicting 30-Day All-Cause Readmission Risk for Subjects Admitted With Pneumonia at the Point of Care.

Hatipoğlu U, Wells BJ, Chagin K, Joshi D, Milinovich A, Rothberg MB.

Respir Care. 2018 Jan;63(1):43-49. doi: 10.4187/respcare.05719. Epub 2017 Oct 24.

8.

Ultrasound in Confirming Central Catheter Position: (Almost) Ready for Prime Time.

Raman D, Hatipoğlu U.

Crit Care Med. 2017 Nov;45(11):e1185-e1186. doi: 10.1097/CCM.0000000000002587. No abstract available.

PMID:
29028709
9.

Impact of Intrathoracic Pressure in the Assessment of Pulmonary Hypertension in Overweight Patients.

Jawad A, Tonelli AR, Chatburn RL, Wang X, Hatipoğlu U.

Ann Am Thorac Soc. 2017 Dec;14(12):1861-1863. doi: 10.1513/AnnalsATS.201704-331RL. No abstract available.

PMID:
28777657
10.

Impact of a Post-Discharge Integrated Disease Management Program on COPD Hospital Readmissions.

Russo AN, Sathiyamoorthy G, Lau C, Saygin D, Han X, Wang XF, Rice R, Aboussouan LS, Stoller JK, Hatipoğlu U.

Respir Care. 2017 Nov;62(11):1396-1402. doi: 10.4187/respcare.05547. Epub 2017 Aug 1.

11.

Utilization of Thoracic Ultrasound for Confirmation of Central Venous Catheter Placement and Exclusion of Pneumothorax: A Novel Technique in Real-Time Application.

Raman D, Sharma M, Moghekar A, Wang X, Hatipoğlu U.

J Intensive Care Med. 2019 Jul;34(7):594-598. doi: 10.1177/0885066617705839. Epub 2017 Apr 26.

PMID:
28443388
12.

Controlled Clinical Trials and Real-Life Experience with Pulmonary Rehabilitation.

Sathiyamoorthy G, Lau C, Marlow S, Hatipoğlu U.

Am J Respir Crit Care Med. 2017 Sep 15;196(6):796-797. doi: 10.1164/rccm.201703-0647LE. No abstract available.

PMID:
28423284
13.

What is the role of roflumilast in chronic obstructive pulmonary disease?

Lau C, Mehta AC, Hatipoglu U.

Cleve Clin J Med. 2017 Jan;84(1):13-15. doi: 10.3949/ccjm.84a.15150. Review. No abstract available.

14.

α1-Antitrypsin Deficiency.

Hatipoğlu U, Stoller JK.

Clin Chest Med. 2016 Sep;37(3):487-504. doi: 10.1016/j.ccm.2016.04.011. Epub 2016 Jun 25. Review.

PMID:
27514595
15.

Treating and preventing acute exacerbations of COPD.

Hatipoglu US, Aboussouan LS.

Cleve Clin J Med. 2016 Apr;83(4):289-300. doi: 10.3949/ccjm.83a.14188. Review.

16.

Intrasubject Variability in Total IgE Levels in Patients with Moderate to Severe Persistent Allergic Asthma Over 1 Year.

Hatipoğlu U, Subramanian A, Campbell T, Rice R, Mummadi S, Hu B, Lang DM.

J Allergy Clin Immunol Pract. 2016 Jul-Aug;4(4):691-696.e1. doi: 10.1016/j.jaip.2016.02.007. Epub 2016 Mar 30.

PMID:
27039239
17.

Extracorporeal membrane oxygenation and toilet bronchoscopy as a bridge to pneumonectomy in severe community-acquired methicillin-resistant Staphylococcus aureus pneumonia.

Panchabhai TS, Khabbaza JE, Raja S, Mehta AC, Hatipoğlu U.

Ann Thorac Med. 2015 Oct-Dec;10(4):292-4. doi: 10.4103/1817-1737.164298.

18.

Determinants of Wake Pco2 and Increases in Wake Pco2 over Time in Patients with Obstructive Sleep Apnea.

Kittivoravitkul P, Kaw R, Hatipoğlu U, Wang L, Aboussouan LS.

Ann Am Thorac Soc. 2016 Feb;13(2):259-64. doi: 10.1513/AnnalsATS.201508-563OC.

PMID:
26636624
19.

Intralobar Pulmonary Sequestration Presenting as Chronic Non-productive Cough.

Gudavalli R, Farver CC, Mason DP, Hatipoglu U.

Indian J Chest Dis Allied Sci. 2015 Jan-Mar;57(1):23-5.

PMID:
26410979
20.

Association Between Postdischarge Pulmonologist Visit and Hospital Readmission.

Hatipoğlu U, Wang X.

Chest. 2015 Aug;148(2):e62. doi: 10.1378/chest.15-0807. No abstract available.

PMID:
26238844
21.

Chronic obstructive pulmonary disease: an update for the primary physician.

Hatipoğlu U, Aboussouan LS.

Cleve Clin J Med. 2014 Jun;81(6):373-83. doi: 10.3949/ccjm.81a.13061. Review.

PMID:
24891539
22.

Interpretation of Neurally Adjusted Ventilatory Assist (NAVA) waveforms.

Chatburn RL, Mireles-Cabodevila E, Hatipoglu U, Rodriguez RJ.

J Crit Care. 2014 Aug;29(4):664. doi: 10.1016/j.jcrc.2014.02.013. Epub 2014 Mar 3. No abstract available.

PMID:
24735520
23.
24.

Pulmonary hepatic nodules.

Talanow R, Hatipoglu US, Graham R.

BMJ Case Rep. 2013 Feb 8;2013. pii: bcr2012006867. doi: 10.1136/bcr-2012-006867. No abstract available.

25.

"Minimal ventilator settings" and extubation.

Hatipoglu U, Chatburn RL, Guzman JA.

Am J Respir Crit Care Med. 2012 Jul 15;186(2):198; author reply 199-200. No abstract available.

PMID:
22798417
26.

A rational framework for selecting modes of ventilation.

Mireles-Cabodevila E, Hatipoğlu U, Chatburn RL.

Respir Care. 2013 Feb;58(2):348-66. doi: 10.4187/respcare.01839. Review. Erratum in: Respir Care. 2013 Apr;58(4):e51.

27.

An older patient with bilateral non-traumatic haemothoraces.

Photowala F, Hatipoglu US, Garcia C.

BMJ Case Rep. 2012 Mar 27;2012. pii: bcr0120125527. doi: 10.1136/bcr.01.2012.5527.

28.

Clinically significant variability of serum IgE concentrations in patients with severe asthma.

Mummadi SR, Hatipoğlu US, Gupta M, Bossard MK, Xu M, Lang D.

J Asthma. 2012 Mar;49(2):115-20. doi: 10.3109/02770903.2011.649871. Epub 2012 Jan 25.

PMID:
22277088
29.

High frequency chest wall oscillation for asthma and chronic obstructive pulmonary disease exacerbations: a randomized sham-controlled clinical trial.

Mahajan AK, Diette GB, Hatipoğlu U, Bilderback A, Ridge A, Harris VW, Dalapathi V, Badlani S, Lewis S, Charbeneau JT, Naureckas ET, Krishnan JA.

Respir Res. 2011 Sep 10;12:120. doi: 10.1186/1465-9921-12-120.

30.

Age, sex and body mass index in relation to calvarial diploe thickness and craniometric data on MRI.

Hatipoglu HG, Ozcan HN, Hatipoglu US, Yuksel E.

Forensic Sci Int. 2008 Nov 20;182(1-3):46-51. doi: 10.1016/j.forsciint.2008.09.014. Epub 2008 Nov 8.

PMID:
18996658
31.

Anti-inflammatory treatment of chronic rhinosinusitis: a shifting paradigm.

Hatipoğlu U, Rubinstein I.

Curr Allergy Asthma Rep. 2008 Apr;8(2):154-61. Review.

PMID:
18417058
32.

Treatment of chronic rhinosinusitis with low-dose, long-term macrolide antibiotics: an evolving paradigm.

Hatipoglu U, Rubinstein I.

Curr Allergy Asthma Rep. 2005 Nov;5(6):491-4. Review.

PMID:
16216175
33.

Inflammation and obstructive sleep apnea syndrome: how many ways do I look at thee?

Hatipoğlu U, Rubinstein I.

Chest. 2004 Jul;126(1):1-2. No abstract available.

PMID:
15249430
34.

Low-dose, long-term macrolide therapy in asthma: An overview.

Hatipoglu U, Rubinstein I.

Clin Mol Allergy. 2004 Mar 16;2(1):4.

35.

Inflammation and obstructive sleep apnea syndrome pathogenesis: a working hypothesis.

Hatipoğlu U, Rubinstein I.

Respiration. 2003 Nov-Dec;70(6):665-71. Review.

PMID:
14732803
36.

Pulmonary vasculitis: a clinical overview.

Hatipoglu U, Rubinstein I.

Isr Med Assoc J. 2002 Dec;4(12):1143-8. Review. No abstract available.

37.

Unilateral expiratory airflow obstruction during forced exhalation.

Hatipoglu U, Laghi F, Cattapan SE, Chandrasekhar AJ.

Respir Care. 2002 Jun;47(6):693-5.

PMID:
12036440
38.

Does inhaled albuterol improve diaphragmatic contractility in patients with chronic obstructive pulmonary disease?

Hatipoğlu U, Laghi F, Tobin MJ.

Am J Respir Crit Care Med. 1999 Dec;160(6):1916-21.

PMID:
10588606
39.

Sterically stabilized phospholipids attenuate human neutrophils chemotaxis in vitro.

Hatipoglu U, Gao X, Verral S, Séjourné F, Pitrak D, Alkan-Onyüksel H, Rubinstein I.

Life Sci. 1998;63(8):693-9.

PMID:
9718098

Supplemental Content

Loading ...
Support Center